If you’ve experienced a heart attack, your healthcare provider may prescribe certain medications to help prevent one from ...

ultrasound-assisted (EKOS Endowave®) Serious DVT and/or PE Directs iv. thrombolytic agent physically within thrombosed area ICU monitoring 24–72 (average 48 h); lytic agent migrates ...

In the acute setting, we agree with MacEwen that thrombolytic thrombolytic therapy in select cases of thrombosis and embolism should be endorsed until further evidence emerges. For longer term ...

At ERS 2024, experts debated systemic thrombolysis vs mechanical and surgical treatments for high-risk pulmonary embolism, ...

"This milestone brings us closer to delivering a next-generation therapy that we believe will offer patients a new targeted thrombolytic option beyond traditional fibrinolytics." RAISE is a two ...

A Data Safety Monitoring Committee has been established to review the safety and efficacy data throughout the study.

A heart attack is a potentially life-threatening medical emergency that can lead to cardiac arrest or death. Heart attacks ...

Ischaemic stroke can lead to permanent neurological damage and often death if not diagnosed and treated promptly. There is therefore an urgent need for novel treatment approaches. Now, writing in ...

Fintel reports that on September 17, 2024, Stifel initiated coverage of Inari Medical (NasdaqGS:NARI) with a Hold ...

H.C. Wainwright analyst Yi Chen reiterated a Buy rating on AngioDynamics (ANGO – Research Report) today and set a price target of $14.00.

People who live in rural communities live an average of three years fewer than urban counterparts and have a 40% higher likelihood of developing heart disease and face a 30% increased risk for stroke ...